Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intact Versus Biointact Assays for Longitudinal Assessment of Parathyroid Hormone - The Longitudinal PTH Study

NCT03464149 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT03464149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03464149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intact Versus Biointact Assays for Longitudinal Assessment of Parathyroid Hormone - The Longitudinal PTH Study
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Completed
Start date
March 20, 2018
Completion date
August 7, 2019
Enrollment
132 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ckd-mbd - chronic kidney disease mineral and bone disorder, kidney replacement, secondary hyperparathyroidism